Dechra Pharmaceuticals plc (DPH.L)

2,591.20 -12.80 (-0.49%) As of 11:40AM BST. Market open.

Dechra Pharmaceuticals plc

24 Cheshire Avenue
Cheshire Business Park Lostock Gralam
Northwich CW9 7UA
United Kingdom
44 1606 814730
https://www.dechra.com

Sector(s): Healthcare
Industry: Drug Manufacturers—General
Full-time employees: 1,998

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Ian D. Page	CEO, MD & Exec. Director	1.26M	N/A	1961
Mr. Paul Nicholas Sandland MAAT, FCCA	CFO & Exec. Director	790k	N/A	1979
Dr. Anthony Gerard Griffin	MD of Dechra Veterinary Products for Europe & Exec. Director	601k	N/A	1963
Mr. Patrick Meeus	Group Scientific Officer	N/A	N/A	N/A
Ms. Katy Clough	Group HR Director	N/A	N/A	N/A
Mr. Mike Eldred	Pres of North America	N/A	N/A	1970
Ms. Melanie Hall	Company Sec.	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

Corporate governance

Dechra Pharmaceuticals plc’s ISS governance QualityScore as of 1 March 2023 is 10. The pillar scores are Audit: 3; Board: 9; Shareholder rights: 10; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.